INTRODUCTION
The seasonal patterns of infectious diseases have been observed for millennia. Seasonality is observed in almost all infectious diseases, from respiratory infections such as influenza and respiratory syncytial virus, 1, 2 to diarrheal diseases such as cholera, 3 and vector borne diseases such as malaria. 4 Despite numerous epidemiological studies investigating infectious disease seasonality, the underlying drivers of this seasonality remain unclear for many infections, and for respiratory infections in particular. Proposed environmental drivers of respiratory infection seasonality include seasonal variations in host contact rates, and seasonal variations in the environmental survival of pathogens. 5 Another proposed driver is seasonal variation in host immunity. Seasonal variations in host resistance to infection have been documented in a number of non-human vertebrates, 6 and there are a number of biologically plausible mechanisms that could result in similar seasonal immune modulation in humans. Seasonal variation in sunshine levels may play a role: it has been proposed that seasonal variations in vitamin D levels could drive respiratory infection incidence, 7 and seasonal variations in photoperiod have also been proposed as a driver of seasonal immune modulation. 8 Exposure to environmental immunotoxins may also vary by season: for example aflatoxin levels are often increased in grain and groundnuts stored in non-harvest seasons. 9 Seasonal variations in nutrition also occur in many settings, and the link between malnutrition and reduced host resistance to infection is well established in children. 10 Infectious diseases and host immunity are linked in a cyclic manner: while depressed immunity increases the risk of clinical infection in those exposed to pathogens, infection itself can debilitate the host, resulting in reduced immune defences. Thus some infectious diseases, driven by external seasonal forces such as climate, may seasonally debilitate human hosts and in turn predispose to secondary infection, resulting in seasonality in this secondary infection. A particularly well documented example is that of diarrheal illness in children predisposing them to subsequent pneumonia. These immune biomarkers are considered to have the best combination of clinical relevance, biological sensitivity and practicality. 13, 14 We have critically reviewed these studies to assess whether seasonal immune modulation occurs in human populations. We also discuss whether the observed variations in immunity can be plausibly linked to respiratory infection seasonality in the study settings. We conclude by recommending a systematic strategy for future studies.
MATERIALS AND METHODS
We searched Medline (search date 18 April 2014) for studies measuring the above biomarkers during different seasons. A keyword search was performed using the following terms:
AB ("immune response*" OR "vaccine response*" OR immunogen* OR "antibody response*" OR "delayed type hypersensitivity" OR anergy) AND AB (summer OR winter OR spring OR autumn OR "wet season" OR "rainy season" OR "dry season")
A MESH term search was performed using the following terms:
((MH "Immunity, Cellular") OR (MH "Immunity, Humoral") OR (MH "Adaptive Immunity")) AND (MH "Seasons")
Search results were restricted to those published in English. We performed citation searches of the retrieved articles, and also searched articles citing the retrieved articles using Google Scholar.
RESULTS

Studies examining vaccine antibody responses
Vaccination elicits antibody production via humoral immunity. For most vaccines, antigen presenting cells are activated by vaccine antigens, and then present these antigens to 1) Blymphocytes, which then differentiate into antibody producing plasma cells, and 2) T-lymphocytes, which facilitate this process (unconjugated polysaccharide vaccines elicit a Tlymphocyte independent response, where the polysaccharide antigen directly binds to Blymphoctes, stimulating their differentiation into antibody producing plasma cells). Thus measuring antibody levels following vaccination provides an in vivo measure of an integrated, clinically relevant immune response. We found 17 studies examining antibody responses according to the season of vaccination. These studies are summarised in Table 1, and discussed below.
Rabies vaccine
Responses to rabies vaccine are a potentially useful biomarker for seasonal analysis because rabies antigen does not circulate widely in the environment. A study in 472 Gambian children aged between 6 and 9 years found a statistically significant seasonal variation in antibody levels following first rabies vaccination, with the strongest antibody responses to rabies vaccine if given in May (late dry season). 15 A study in 257 adults in Pakistan found that antibody levels following rabies vaccination (two doses given seven days apart) showed a statistically significant monthly variation, with highest responses in August, during the peak of summer. 16 However because the study only included the months from April to September, it cannot fully address the question of seasonality.
Hepatitis B virus (HBV) vaccine
A study in 522 young adults in the Netherlands found little variation in antibody levels according to the season of first HBV vaccination (given at 0, 1 and 6 months). 17 A study in 138 infants in the Gambia found the highest responses to HBV vaccine (given at 0, 8 and 16
weeks of age) in infants vaccinated in October and November, however this was not statistically significant. 16 A study in 1874 older children and adults in Austria found significantly higher antibody levels following a course of HBV vaccine (given at 0, 1 and 6 to 12 months) if the third vaccination was performed in winter compared to summer. 18 Interpretation of this latter finding is difficult due to the multiple doses of vaccine given across different seasons, as well as the variable period between first and third vaccination. In addition, antibody responses were measured between 4 weeks and 5 years after finishing the HBV vaccine course.
A study in 203 children in Israel found that children receiving a single dose of measles, mumps and rubella (MMR) vaccine in the summer had significantly lower rubella antibody levels than children vaccinated in the winter. 19 Children received MMR at age 12 months (±10 days), and antibody levels were measured when the children were 4 to 5 years old. Due to high vaccine coverage rates, rubella incidence has been very low in Israel since the late 1990s, suggesting that environmental exposure to rubella antigens is unlikely to have been driving the seasonal variation. 20 A study in 718 children in the Netherlands found no differences in antibody levels against measles or rubella according to season of receiving MMR vaccination. 17 These children received MMR at age 14 months, and antibody levels were measured at 2 to 7 years of age.
Pneumococcal vaccines
Antibody levels following a single dose of pneumococcal polysaccharide vaccine in 472 children aged 6 to 9 years in the Gambia showed complex variation according to the month of vaccination, with different seasonal patterns for different serotypes 15, 16 As part of a Gambian vaccine trial, antibody responses following three doses of pneumococcal conjugate vaccine (given at 6, 10 and 14 weeks of age) were assessed according to the season of vaccination in 212 children. Children who received all three doses of vaccine in the rainy season had higher antibody levels than those who received doses across both the dry and rainy seasons.
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Pneumococcal antigens circulate cyclically in the environment, 22 and exposure to pneumococcal antigens is known to interfere with the immunogenicity of pneumococcal vaccines. 23, 24 Thus examining the immunogenicity of pneumococcal vaccines according to the season of vaccination is particularly vulnerable to confounding from environmental antigens, which may explain the inconsistent results from these studies.
Diphtheria and tetanus vaccines
A study in 138 infants in the Gambia found little variation in antibody responses to diphtheria or tetanus according to the month of vaccination. 16 Infants were vaccinated with combined diphtheria, tetanus and pertussis vaccine at 8, 12 and 16 weeks of age, and antibody levels were measured at 16 weeks of age.
Typhoid vaccine
A study in 257 adults in Pakistan showed little variation in antibody response according to month of vaccination with typhoid vaccine (As noted above however, this study only included the months from April to September). 16 
Live influenza vaccines
Two studies in the former USSR found the highest antibody responses to live intranasal influenza vaccines occurred in individuals vaccinated in the winter. In the first study 584 males aged 16 to 18 years were vaccinated either in June or January. Seroconversion (defined as a fourfold or greater increase in antibody levels compared to before vaccination) was assessed 20 to 25 days after vaccination, and occurred in 38% of those vaccinated in June and 51% of those vaccinated in January. 25 The second study included 588 subjects aged 16 to 18
years. Those vaccinated in the summer had a lower seroconversion rate (defined as above) 21 days after vaccination compared to those vaccinated in winter (16% in summer, compared to 23% in winter).
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Oral polio vaccine (OPV)
A study in 121 infants in Israel found higher seroconversion rates in infants vaccinated with OPV in winter compared to summer. 27 A study in 50 infants in India also found higher seroconversion rates in those infants vaccinated in the winter months. 28 In the Gambia, a study in 679 infants found those infants receiving more OPV vaccinations in the rainy season had a lower seroconversion rate. 29 In contrast to these three studies, a study in 730 infants in Brazil did not find any significant variation in OPV immunogenicity according to the season of vaccination. 29 A major driver of the observed seasonal variations in OPV antibody responses appears to be the seasonal variation in the prevalence of non-polio enteroviruses:
infants vaccinated when non-polio enterovirus circulation was at its peak had poorer antibody responses to OPV. [27] [28] [29] [30] This strong environmental determinant of OPV immunogenicity reduces the usefulness of OPV for assessing seasonal immune modulation.
Studies examining DTH responses
DTH testing involves the intradermal injection of one or more antigens. If the antigen has been encountered previously by the individual, this will elicit a cell mediated immune response: antigen presenting cells are activated by the intradermal antigens, and then present these antigens to memory T-cells, which in turn release cytokines resulting in an infiltration of various inflammatory cells. Thus DTH testing provides an in vivo measure of an integrated, clinically relevant immune response. The width of the skin induration due to the inflammatory response is measured 48 hours after injection of the antigen. Induration less than a specific cut off (usually 2mm) is indicative of anergy to that antigen. We found 5 studies examining DTH responses according to the season of testing. These studies are summarised in Table 2 , and discussed below.
Several studies have examined DTH responses to the seven skin test antigens included in the multitest kit (proteus, trichophyton, candida, tetanus, diphtheria, streptococcus, and tuberculin). In the Gambia, 472 children aged between 6 and 9 years underwent DTH skin testing with these seven antigens, with a single administration of the multitest at different times of the year in different children. Consistent with the results from the rabies vaccination study in this same population, the average number of positive responses to the seven antigens was highest in April/May (late dry season). 15 A study in southern Bangladesh followed a cohort of 705 children aged between zero and five years over the course of a year, administering the seven multitest antigens at three month intervals. A potential weakness of this study was the use of repeated DTH testing in the same children, because repeated DTH however the study only examined 5 months of the year, and only one of these months (May) was during the dry season.
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Experimental infection: clinical outcomes following the administration of live vaccines
Experimental infection provides the most clinically relevant assessment of immune defences against infection. Innate, cellular, and humoral immune responses will all be elicited to varying degrees to reduce the intensity of infection. Measured outcomes may be symptomatology of infection, or microbiological outcomes such as ongoing pathogen isolation. We found two studies examining clinical responses according to the season of experimental infection. These studies are summarised in Table 3 , and discussed below.
As discussed above, two studies in the former USSR examined human challenge with live influenza vaccine in non-immune volunteers. The first of these reported a higher risk of fever in 360 individuals vaccinated during the winter compared to 197 vaccinated in summer.
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Although influenza and other viruses causing febrile illness are more common in the winter in the study setting, it appears the increased risk of fever in those individuals vaccinated in the winter was a direct result of the influenza vaccination, as the placebo group did not show any signs of fever during the winter vaccine challenge. The other study from the former USSR reported similar results, with a significantly higher risk of fever following influenza vaccination in the winter compared to in the summer, and a significantly higher amount of nasal secretion of vaccine virus two and three days following vaccination in winter compared to summer. 26 Taken together these studies suggest that in winter, vaccinated individuals are more likely to become infected with the vaccine viruses, with subsequent viral replication and fever.
DISCUSSION
Sources of bias in the retrieved studies
During our critical appraisal of the studies retrieved by our literature search, we identified a number of sources of bias specific to studies comparing immune status at different time of the year. These sources of bias are discussed below, and in Tables 1 to 3 we also indicate which studies are at risk of these biases. 
Circulating antigens
Follow-up time following challenge
The strength of an immune response also varies with time following challenge. For DTH testing, skin tests are routinely read 48 hours after challenge. For vaccinations the follow-up time is less consistent. Follow-up times must be equal following challenges in different seasons to avoid confounding, and it would be prudent to test antibody responses within one to two months following vaccination (some of the reviewed studies measured antibody levels several years following vaccination, allowing the potential for other environmental factors to influence the immune response in the interim). Follow-up times should also be equal for studies using experimental infection, as symptoms will vary with time following infection, according to the incubation period.
Repeated immune challenges
Repeat immune challenges with the same antigen may lead to boosting of later responses. For DTH testing the available evidence suggests such boosting is probably maximal if DTH tests are repeated within two months, however some boosting may occur if DTH tests are repeated up to a year later. [42] [43] [44] [45] The boosting effect of repeated vaccination is well known. The simplest way to avoid bias due to boosting is to assess immune responses to antigen challenge in different subjects at different times of the year.
Antigen storage
The immunogenicity of antigens depends on adequate storage, in particular the maintenance of the cold chain during transport and storage. In many settings maintaining the cold chain may be more difficult at different times of the year. High temperatures in summer, and difficulties in transport during the rainy season, are two seasonal factors that may be detrimental to proper vaccine storage. Most of the reviewed papers have documented the efforts taken to maintain the cold chain during the studies. No papers reported any observed problems with cold chain maintenance. Table 4 lists the studies least likely to be affected by the sources of bias discussed above, and include studies using rabies vaccine (1 study), multitest DTH responses (3 studies), and experimental infection (2 studies). Possible drivers of the observed seasonal variation in immunity in these six studies are discussed below.
Possible drivers of seasonal immune modulation
In the Gambia, immune responses in children following both rabies vaccine and DTH multitest were strongest late in the dry season (April/May). Similarly, in nearby GuineaBissau, anergy to the DTH multitest in children was less common in May than during the rainy season. In this part of West Africa the rainy season is often a time of poor nutrition known as the hungry season, 46, 47 and this malnutrition is exacerbated by an increased incidence of diarrheal illness during the rainy season. 4, 48 A number of studies have demonstrated a direct link between poor nutritional status, reduced cell mediated immune responses, and an increased risk of infection in children. 31, [49] [50] [51] In contrast, vaccine responses appear less affected by malnutrition. 52 Malaria infection is also at its peak during the rainy season, driven by increased mosquito numbers. Malaria infection appears to affect host immunity: malaria parasitaemia reduces the antibody response to some vaccines and malaria parasitaemia also appears to affect DTH responses to some antigens. [53] [54] [55] In the Gambian study, children with malaria parasitaemia had reduced responses to the rabies vaccine, but parasitaemia did not affect DTH testing. Whatever the cause of the apparent reduction in both cell mediated and humoral immunity during the rainy season in this setting, it appears plausible that this seasonal reduction in immunity may drive further infections. Respiratory infections in children are generally at their peak late in the rainy season in the Gambia. 56 The timing of this peak is consistent with respiratory infection seasonality being at least partly driven by the observed seasonal reduction in cellular and/or humoral immunity.
In Bangladesh, anergy to all seven DTH multitest antigens was more common upon testing in the rainy season compared to the hot dry season. As with the West African examples, in
Bangladesh the rainy season is often a time of poor nutrition, with reduced household food security and decreased maternal and child growth. 57, 58 Malaria is not endemic in the district the DTH study was performed in. It is plausible that the observed seasonal reduction in cellular immunity may play a role in driving the seasonality of respiratory infections in this setting. Respiratory infections in children generally occur at two times of the year in Bangladesh: during the winter, and late in the rainy season. 59, 60 The timing of the second peak is consistent with respiratory infection incidence being at least partly driven by the observed seasonal reduction in cell mediated immunity.
In young adults in the temperate climate of the former USSR, fever and viral secretion were vitamin D deficiency appears to increase the risk of respiratory infection in children. [62] [63] [64] The most specific effect of vitamin D deficiency on immunity is a reduction in the antimicrobial peptide cathelicidin, part of the innate immune system, and expressed in leukocytes and bronchial epithelial cells. 65, 66 In this temperate setting, respiratory infections are most common in late winter/early spring. 67, 68 While improved viral survival due to the low winter temperatures in temperate settings is one plausible driver of this seasonal variation in respiratory infections, reduced immune competence during the winter may also play a role in driving the observed seasonality of respiratory infections.
CONCLUSIONS
The studies reviewed here suggest seasonal immune modulation occurs in humans, and that seasonal immune modulation in humans is a plausible driver of the observed seasonal  For vaccines, use antigens that do not circulate in the environment.
 For DTH testing, assess anergy to a number of test antigens administered at the same time.
 To avoid confounding, maintain similar age and sex distributions of children in the comparison groups (or control for any differences in analysis).
 Administer the antigen challenge to children over a range of ages in order to control for birth cohort effects.
 For vaccines, testing the antibody response after a single dose will give clearer results.
 Avoid repeated challenges in the same subjects as this can cause boosting of responses.
 The delay between the immune challenge and measurement of the immune response should be the same in the comparison groups (and it would be prudent to test antibody levels within two months of vaccination).
 Ensure cold chain maintenance is the same during different seasons. 
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